Altamira Therapeutics Ltd (CYTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1987 | 12-1986 | 12-1985 | 12-1984 | 12-1983 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 1,494 | 962 | 58 | 117 | 0 |
| TOTAL | $1,494 | $962 | $58 | $117 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 5,389 | 1,517 | 642 | 582 | N/A |
| Other Non-Current Assets | 106 | 55 | 96 | 33 | 0 |
| TOTAL | $5,495 | $1,572 | $738 | $614 | $N/A |
| Total Assets | $6,989 | $2,533 | $796 | $731 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 467 | 417 | 182 | 157 | 0 |
| Accrued Expenses | 1,727 | 755 | 322 | 401 | N/A |
| Other current liabilities | 0 | 0 | 900 | 0 | N/A |
| TOTAL | $2,199 | $1,188 | $1,420 | $571 | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $8 | $24 | $39 | $N/A |
| Total Liabilities | $2,199 | $1,196 | $1,443 | $611 | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 119 | 119 | 74 | 73 | N/A |
| Other shareholders' equity | -104 | -154 | -204 | -204 | 0 |
| TOTAL | $61,086 | $60,958 | $10,274 | $9,598 | $N/A |
| Total Liabilities And Equity | $63,285 | $62,154 | $11,717 | $10,208 | $0 |